CN104083442A - Traditional Chinese medicine composition for treating allergic rhinitis - Google Patents
Traditional Chinese medicine composition for treating allergic rhinitis Download PDFInfo
- Publication number
- CN104083442A CN104083442A CN201410340567.3A CN201410340567A CN104083442A CN 104083442 A CN104083442 A CN 104083442A CN 201410340567 A CN201410340567 A CN 201410340567A CN 104083442 A CN104083442 A CN 104083442A
- Authority
- CN
- China
- Prior art keywords
- allergic rhinitis
- chinese medicine
- parts
- medicine composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating allergic rhinitis. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 13-17 parts of selfheal, 8-12 parts of flos magnolia, 2-4 parts of asarum and 0.2-0.4 part of borneol. The traditional Chinese medicine composition is an external drug, and has the advantages of inflammation reduction, sterilization and elimination of toxicant, no possibility of reappearance and the like.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of Chinese medicine composition that is used for the treatment of allergic rhinitis.
Background technology
Allergic rhinitis main manifestations is rhinocnesmus, sneeze, nasal obstruction, watery nasal discharge, and some patients were is also with discomforts such as dry nasal cavity, headache, ophthalmic pruritus, and this sick sickness rate is higher, approximately has the people of 20% left and right to suffer from allergic rhinitis.
Allergic rhinitis claims again allergic rhinitis, it is the allergic disease of nasal membrane, separately there is a type to be brought out by nonspecific stimulation, participate in without specific allergen, it not immunoreaction process, but clinical manifestation is similar to above-mentioned amphitypy allergic rhinitis, claim vasomotor rhinitis or claim neural reflex rhinitis, stimulation can be from external (physics, chemistry aspect), or (endocrine ex vivo, spirit aspect), therefore someone regards as is allergic rhinitis, but because there is not antigen-antibody reaction in body, so desensitization therapy, hormone or immunotherapy are all invalid.
Expert points out, treatment of allergic rhinitis, is first to avoid contact allergy former, there is no Allergic Rhinitis without anaphylactogen.Next is the treatment of carrying out specification, and at present, the Therapeutic Method of allergic rhinitis has a lot, comprise and avoid therapy, general treatement, Drug therapy, desensitization treatment, operative treatment etc., so, does is which kind of method only best?
The general pharmacotherapy that uses at present: the Drug therapy of allergic rhinitis is taking antihistaminic as main, due to antihistaminic have multiple and also everyone resist the body constitution difference of its drowsiness side effect, there is in addition parasympathomimetic agent to strengthen sympathetic nerve function, the but side effect of had palpitation, also needs careful in use.
Inject in addition desensitization treatment, anaphylactogen injection desensitization treatment refers to and carries out intradermal injection with anaphylactogen extract.Desensitization injection, from low dose, increases dosage, gradually to increase the toleration to anaphylactogen.Injection desensitization treatment generally at least needs 2～3 years, and long-term injection can bring certain misery.
Or sublingual administration desensitization is controlled, sublingual administration desensitization treatment is to bring out irritated material (as dirt demodicid mite activated protein) and make the desensitization liquid of variable concentrations, with adaptable low dose of administration every day of patient, (drop that will desensitize drips in Sublingual, it is slowly absorbed, under 1～3 minute posterior phraynx), increased dosage amount gradually, reaches after the level of maintaining and continues enough time, to improve patient's tolerance.
But above method has side effect to a certain degree, and be difficult to be completely cured, patient is easily recurred.
Summary of the invention
The invention provides a kind of Chinese medicine composition that is used for the treatment of allergic rhinitis, for medicine for external use, this product is nearly over one hundred year secret prescription handed down in the family from generation to generation, there is clinical use checking for many years, effect spy is good, without any side effects, and allergic rhinitis is had to good treatment, prevention, health-care effect, can be completely cured, be not easy recurrence.
Concrete technical scheme of the present invention is a kind of Chinese medicine composition that is used for the treatment of allergic rhinitis, is made up of the raw material of following weight portion: Spica Prunellae 13-17 part, Flos Magnoliae 8-12 part, Herba Asari 2-4 part, Borneolum Syntheticum 0.2-0.4 part.
A kind of Chinese medicine composition that is used for the treatment of allergic rhinitis is made up of the raw material of following preferred weight portion: 15 parts of Spica Prunellaes, 10 parts of Flos Magnoliaes, 3 parts of Herba Asaris, 0.3 part of Borneolum Syntheticum.
Above-mentioned raw materials is all on the books on Chinese medicine voluminous dictionary, is described as follows:
Spica Prunellae, is commonly called as cattle enemy, claims again to do in nine Rhizoma Paridis, ferrum color grass, large headdress flower, excellent stigma flower, Intestinum caprae seu ovis dish, hammer grass, June, caput post etc., and the improving eyesight of can relieving inflammation or internal heat, can control the effect such as conjunctival congestion and swelling pain, headache, and Spica Prunellae is liver heat removing, hepatoprotective " panacea ".
Flos Magnoliae is Magnolia liliiflora, and Magnoliaceae Magnolia has another name called Drymotaenium miyoshianum (Mak.) Mak., Flos Magnoliae, is Chinese endemic plant, be distributed in the ground such as Chinese yunnan, Fujian, Hubei, Sichuan, grow in the area of 300 meters to 1,600 meter of height above sea level, generally be grown in hillside border, abnormal smells from the patient is pungent, warm, nontoxic, cures mainly nasal sinusitis, nasal obstruction.
Herba Asari, has another name called: magnificent Herba Asari, little Xin, few pungent, careless Herba Asari of basin etc., cure mainly: dispel the wind, and cold expelling, row water, have one's ideas straightened out, control air-cooled headache, nasal sinusitis, toothache, phlegm retention cough with dyspnea, rheumatic arthralgia, Herba Asari can outer dispersing wind and cold, again can in the YIN-cold of dispelling, pain relieving simultaneously, antitussive effect are better.
Borneolum Syntheticum, has another name called sheet brain, Fructus Citri tangerinae sheet, Borneolum Syntheticum, MEIHUA BINGPIAN, Dipterocarpus pilosus, Flos Mume brain, Borneolum Syntheticum brain, Mei Bing etc., and it can be used for excess syndrome of stroke coma, for conjunctival congestion and swelling pain, sore throat aphtha, swells and ache for skin infection, does not hold back etc. after bursting.
Pharmacology of the present invention is that above Chinese herbal medicine compatibility forms, invigorating QI to consolidate the body surface resistance, and antiinflammatory, sterilization toxin expelling, heat clearing away, reaches the effect for the treatment of rhinitis.
Using method of the present invention is to grind altogether superfine end, with a little medicamental pulverata suction intranasal, every day 2-3 time.
The invention has the beneficial effects as follows: this product is Chinese herbal medicine among the people, fully natural green medical material is without any side effects, can fine treatment of allergic rhinitis, and not easily to recur.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details, but is not limitation of the present invention.
1 one kinds of Chinese medicine compositions that are used for the treatment of allergic rhinitis of embodiment are made up of the raw material of following weight portion: 13 parts of Spica Prunellaes, 8 parts of Flos Magnoliaes, 2 parts of Herba Asaris, 0.2 part of Borneolum Syntheticum.
Be prepared into smalls powder by conventional method.
2 one kinds of Chinese medicine compositions that are used for the treatment of allergic rhinitis of embodiment are made up of the raw material of following preferred weight portion: 15 parts of Spica Prunellaes, 10 parts of Flos Magnoliaes, 3 parts of Herba Asaris, 0.3 part of Borneolum Syntheticum
Preparation method is with embodiment 1.
3 one kinds of Chinese medicine compositions that are used for the treatment of allergic rhinitis of embodiment are made up of the raw material of following weight portion: 17 parts of Spica Prunellaes, 12 parts of Flos Magnoliaes, 4 parts of Herba Asaris, 0.4 part of Borneolum Syntheticum.
Preparation method is with embodiment 1.
Embodiment 4 cases:
1, dragon so-and-so, female, 28 years old, allergic rhinitis, main manifestations is rhinocnesmus, old sneeze, often nasal obstruction, watery nasal discharge, uses medicine of the present invention, sucks intranasal with a little medicamental pulverata, every day 2-3 time, treats one month, disease disappears completely, within now nearly 2 years, does not recur.
2, Chen, man, 36 years old, allergic rhinitis, main manifestations is rhinocnesmus, sneeze, dry nasal cavity, headache, uses medicine of the present invention, with a little medicamental pulverata suction intranasal, every day 2-3 time, treats 2 months, disease disappears completely, does not recur again.
3, Lee, female, 43 years old, allergic rhinitis, main manifestations is rhinocnesmus, sneeze, nasal obstruction, watery nasal discharge, and the discomforts such as ophthalmic pruritus are used medicine of the present invention, and with a little medicamental pulverata suction intranasal, every day 2-3 time, treatment one and a half months, disease disappears completely.
4, Cui so-and-so, man, 45 years old, allergic rhinitis, main manifestations is rhinocnesmus, sneeze, nasal obstruction, watery nasal discharge, uses medicine of the present invention, sucks intranasal with a little medicamental pulverata, every day 2-3 time, treats one month, disease disappears completely.
Claims (2)
1. be used for the treatment of a Chinese medicine composition for allergic rhinitis, it is characterized in that being formed by the raw material of following weight portion: Spica Prunellae 13-17 part, Flos Magnoliae 8-12 part, Herba Asari 2-4 part, Borneolum Syntheticum 0.2-0.4 part.
2. a kind of Chinese medicine composition that is used for the treatment of allergic rhinitis according to claim 1, is characterized in that being made up of the raw material of following preferred weight portion: 15 parts of Spica Prunellaes, 10 parts of Flos Magnoliaes, 3 parts of Herba Asaris, 0.3 part of Borneolum Syntheticum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410340567.3A CN104083442A (en) | 2014-07-17 | 2014-07-17 | Traditional Chinese medicine composition for treating allergic rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410340567.3A CN104083442A (en) | 2014-07-17 | 2014-07-17 | Traditional Chinese medicine composition for treating allergic rhinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104083442A true CN104083442A (en) | 2014-10-08 |
Family
ID=51631270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410340567.3A Pending CN104083442A (en) | 2014-07-17 | 2014-07-17 | Traditional Chinese medicine composition for treating allergic rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104083442A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547284A (en) * | 2014-12-20 | 2015-04-29 | 何庆军 | Medicine for treating rhinopathy and preparation method thereof |
-
2014
- 2014-07-17 CN CN201410340567.3A patent/CN104083442A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| （明）李时珍著；御史编译: "《新编本草纲目：百话精译》", 30 September 2009, 北京科学技术出版社 * |
| 周珉等主编: "《过敏性疾病的中医治疗》", 31 December 1995, 上海中医药大学出版社 * |
| 谭兴贵编著: "《中国民间特色疗法》", 31 December 2006, 湖南科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547284A (en) * | 2014-12-20 | 2015-04-29 | 何庆军 | Medicine for treating rhinopathy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104491767A (en) | Chinese medicinal composition for relieving pain and preparation method thereof | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN101129681A (en) | Plaster for treating arthritis | |
| CN101152354A (en) | Traditional Chinese medicine for treating acute dacryocystitis | |
| CN102988641B (en) | Externally applied medicinal liquor for strongly dredging main and collateral channels | |
| CN103142700A (en) | Externally applied liniment for treating premature ejaculation | |
| CN104173782A (en) | Medicine treating urinary calculi | |
| CN104083442A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN102274276B (en) | Traditional Chinese medicinal composition for treating wind-cold type common cold | |
| CN102166272B (en) | Medicament for treating hemorrhoids and preparation method thereof | |
| CN104056203A (en) | External-use traditional Chinese medicine for treating dampness and hotness obstruction type chronic prostatitis | |
| CN101129858A (en) | Plaster for treating cervical vertebra/lumbar disease | |
| CN103585597B (en) | A kind of for alleviating because renal calculus causes the Chinese medicine composition had an intense pain | |
| CN102397326A (en) | Formula of Chinese angelica-motherwort herb decoction and preparation thereof | |
| CN110833615A (en) | A Chinese medicinal composition for treating chronic rhinitis by umbilical therapy, and its preparation method | |
| CN104435560A (en) | Traditional Chinese medicine composition for relieving wound pain after wear-off of anesthetic and preparation method of traditional Chinese medicine composition | |
| CN104623381A (en) | Traditional-Chinese-medicine composition for treating skin disease caused by blood heat and liver depression | |
| CN103599253B (en) | Traditional Chinese medicine composition for treating winter pruritus of old people | |
| CN102872210B (en) | Traditional Chinese medicine for treating urticaria | |
| CN104922279A (en) | External use traditional Chinese medicine composition for treating chronic rhinitis and preparing method of external use traditional Chinese medicine composition | |
| CN101422545B (en) | External spraying agent for treating rhinitis and preparation method thereof | |
| CN103735726A (en) | Chinese patent medicine for treating cutaneous pruritus and preparation method thereof | |
| CN105194634A (en) | Traditional Chinese medicine composition for abating fever of children and preparation method of traditional Chinese medicine composition | |
| CN104825566A (en) | Bee needle attenuation and effect-increase oral liquid and preparation method thereof | |
| CN104587236A (en) | Wind-heat common cold treating drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141008 |
|
| WD01 | Invention patent application deemed withdrawn after publication |